List of Tables
Table 1. Global Benign Prostatic Hyperplasia Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Benign Prostatic Hyperplasia Stent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Benign Prostatic Hyperplasia Stent Market Competitive Situation by Manufacturers in 2024
Table 4. Global Benign Prostatic Hyperplasia Stent Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Benign Prostatic Hyperplasia Stent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Benign Prostatic Hyperplasia Stent Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Benign Prostatic Hyperplasia Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Benign Prostatic Hyperplasia Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Benign Prostatic Hyperplasia Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Benign Prostatic Hyperplasia Stent, Product Type & Application
Table 12. Global Key Manufacturers of Benign Prostatic Hyperplasia Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Benign Prostatic Hyperplasia Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Stent as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Benign Prostatic Hyperplasia Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Benign Prostatic Hyperplasia Stent Sales by Region (2020-2025) & (Units)
Table 18. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Region (2020-2025)
Table 19. Global Benign Prostatic Hyperplasia Stent Sales by Region (2026-2031) & (Units)
Table 20. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Region (2026-2031)
Table 21. Global Benign Prostatic Hyperplasia Stent Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Region (2020-2025)
Table 23. Global Benign Prostatic Hyperplasia Stent Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Region (2026-2031)
Table 25. North America Benign Prostatic Hyperplasia Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Benign Prostatic Hyperplasia Stent Sales by Country (2020-2025) & (Units)
Table 27. North America Benign Prostatic Hyperplasia Stent Sales by Country (2026-2031) & (Units)
Table 28. North America Benign Prostatic Hyperplasia Stent Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Benign Prostatic Hyperplasia Stent Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Benign Prostatic Hyperplasia Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Benign Prostatic Hyperplasia Stent Sales by Country (2020-2025) & (Units)
Table 32. Europe Benign Prostatic Hyperplasia Stent Sales by Country (2026-2031) & (Units)
Table 33. Europe Benign Prostatic Hyperplasia Stent Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Benign Prostatic Hyperplasia Stent Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Benign Prostatic Hyperplasia Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Benign Prostatic Hyperplasia Stent Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Benign Prostatic Hyperplasia Stent Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Benign Prostatic Hyperplasia Stent Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Benign Prostatic Hyperplasia Stent Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Benign Prostatic Hyperplasia Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Benign Prostatic Hyperplasia Stent Sales by Country (2020-2025) & (Units)
Table 42. Latin America Benign Prostatic Hyperplasia Stent Sales by Country (2026-2031) & (Units)
Table 43. Latin America Benign Prostatic Hyperplasia Stent Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Benign Prostatic Hyperplasia Stent Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Benign Prostatic Hyperplasia Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Benign Prostatic Hyperplasia Stent Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Benign Prostatic Hyperplasia Stent Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Benign Prostatic Hyperplasia Stent Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Benign Prostatic Hyperplasia Stent Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Benign Prostatic Hyperplasia Stent Sales (Units) by Type (2020-2025)
Table 51. Global Benign Prostatic Hyperplasia Stent Sales (Units) by Type (2026-2031)
Table 52. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Type (2020-2025)
Table 53. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Type (2026-2031)
Table 54. Global Benign Prostatic Hyperplasia Stent Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Benign Prostatic Hyperplasia Stent Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Type (2020-2025)
Table 57. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Type (2026-2031)
Table 58. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Type (2020-2025)
Table 59. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Type (2026-2031)
Table 60. Global Benign Prostatic Hyperplasia Stent Sales (Units) by Application (2020-2025)
Table 61. Global Benign Prostatic Hyperplasia Stent Sales (Units) by Application (2026-2031)
Table 62. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Application (2020-2025)
Table 63. Global Benign Prostatic Hyperplasia Stent Sales Market Share by Application (2026-2031)
Table 64. Global Benign Prostatic Hyperplasia Stent Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Benign Prostatic Hyperplasia Stent Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Application (2020-2025)
Table 67. Global Benign Prostatic Hyperplasia Stent Revenue Market Share by Application (2026-2031)
Table 68. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Application (2020-2025)
Table 69. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Application (2026-2031)
Table 70. Almirall Company Information
Table 71. Almirall Description and Business Overview
Table 72. Almirall Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Almirall Benign Prostatic Hyperplasia Stent Product
Table 74. Almirall Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Company Information
Table 76. Teva Pharmaceutical Industries Description and Business Overview
Table 77. Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Stent Product
Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
Table 80. MannKind Company Information
Table 81. MannKind Description and Business Overview
Table 82. MannKind Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. MannKind Benign Prostatic Hyperplasia Stent Product
Table 84. MannKind Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck Benign Prostatic Hyperplasia Stent Product
Table 89. Merck Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mylan Benign Prostatic Hyperplasia Stent Product
Table 94. Mylan Recent Developments/Updates
Table 95. Sanofi Company Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Benign Prostatic Hyperplasia Stent Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Aptar Group Company Information
Table 101. Aptar Group Description and Business Overview
Table 102. Aptar Group Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Aptar Group Benign Prostatic Hyperplasia Stent Product
Table 104. Aptar Group Recent Developments/Updates
Table 105. AstraZeneca Company Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. AstraZeneca Benign Prostatic Hyperplasia Stent Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Novartis Company Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Novartis Benign Prostatic Hyperplasia Stent Product
Table 114. Novartis Recent Developments/Updates
Table 115. Chiesi Farmaceutici Company Information
Table 116. Chiesi Farmaceutici Description and Business Overview
Table 117. Chiesi Farmaceutici Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Chiesi Farmaceutici Benign Prostatic Hyperplasia Stent Product
Table 119. Chiesi Farmaceutici Recent Developments/Updates
Table 120. Vectura Group Company Information
Table 121. Vectura Group Description and Business Overview
Table 122. Vectura Group Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Vectura Group Benign Prostatic Hyperplasia Stent Product
Table 124. Vectura Group Recent Developments/Updates
Table 125. Cipla Company Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Cipla Benign Prostatic Hyperplasia Stent Product
Table 129. Cipla Recent Developments/Updates
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Boehringer Ingelheim Benign Prostatic Hyperplasia Stent Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. GlaxoSmithKline Company Information
Table 136. GlaxoSmithKline Description and Business Overview
Table 137. GlaxoSmithKline Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. GlaxoSmithKline Benign Prostatic Hyperplasia Stent Product
Table 139. GlaxoSmithKline Recent Developments/Updates
Table 140. Systematic Review Solutions Company Information
Table 141. Systematic Review Solutions Description and Business Overview
Table 142. Systematic Review Solutions Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Systematic Review Solutions Benign Prostatic Hyperplasia Stent Product
Table 144. Systematic Review Solutions Recent Developments/Updates
Table 145. Allium Medical Solutions Company Information
Table 146. Allium Medical Solutions Description and Business Overview
Table 147. Allium Medical Solutions Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Allium Medical Solutions Benign Prostatic Hyperplasia Stent Product
Table 149. Allium Medical Solutions Recent Developments/Updates
Table 150. Huikai Medical Company Information
Table 151. Huikai Medical Description and Business Overview
Table 152. Huikai Medical Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Huikai Medical Benign Prostatic Hyperplasia Stent Product
Table 154. Huikai Medical Recent Developments/Updates
Table 155. Yigao Medical Company Information
Table 156. Yigao Medical Description and Business Overview
Table 157. Yigao Medical Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Yigao Medical Benign Prostatic Hyperplasia Stent Product
Table 159. Yigao Medical Recent Developments/Updates
Table 160. GRIMED Medical Company Information
Table 161. GRIMED Medical Description and Business Overview
Table 162. GRIMED Medical Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. GRIMED Medical Benign Prostatic Hyperplasia Stent Product
Table 164. GRIMED Medical Recent Developments/Updates
Table 165. Micro-Tech Company Information
Table 166. Micro-Tech Description and Business Overview
Table 167. Micro-Tech Benign Prostatic Hyperplasia Stent Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Micro-Tech Benign Prostatic Hyperplasia Stent Product
Table 169. Micro-Tech Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Benign Prostatic Hyperplasia Stent Distributors List
Table 173. Benign Prostatic Hyperplasia Stent Customers List
Table 174. Benign Prostatic Hyperplasia Stent Market Trends
Table 175. Benign Prostatic Hyperplasia Stent Market Drivers
Table 176. Benign Prostatic Hyperplasia Stent Market Challenges
Table 177. Benign Prostatic Hyperplasia Stent Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Benign Prostatic Hyperplasia Stent
Figure 2. Global Benign Prostatic Hyperplasia Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia Stent Market Share by Type: 2024 & 2031
Figure 4. Temporary Prostatic Stent Product Picture
Figure 5. Permanent Prostatic Stent Product Picture
Figure 6. Global Benign Prostatic Hyperplasia Stent Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Benign Prostatic Hyperplasia Stent Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Benign Prostatic Hyperplasia Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Benign Prostatic Hyperplasia Stent Market Size (2020-2031) & (US$ Million)
Figure 13. Global Benign Prostatic Hyperplasia Stent Sales (2020-2031) & (Units)
Figure 14. Global Benign Prostatic Hyperplasia Stent Average Price (US$/Unit) & (2020-2031)
Figure 15. Benign Prostatic Hyperplasia Stent Report Years Considered
Figure 16. Benign Prostatic Hyperplasia Stent Sales Share by Manufacturers in 2024
Figure 17. Global Benign Prostatic Hyperplasia Stent Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Benign Prostatic Hyperplasia Stent Players: Market Share by Revenue in Benign Prostatic Hyperplasia Stent in 2024
Figure 19. Benign Prostatic Hyperplasia Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Benign Prostatic Hyperplasia Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Benign Prostatic Hyperplasia Stent Sales Market Share by Country (2020-2031)
Figure 22. North America Benign Prostatic Hyperplasia Stent Revenue Market Share by Country (2020-2031)
Figure 23. United States Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Benign Prostatic Hyperplasia Stent Sales Market Share by Country (2020-2031)
Figure 26. Europe Benign Prostatic Hyperplasia Stent Revenue Market Share by Country (2020-2031)
Figure 27. Germany Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Benign Prostatic Hyperplasia Stent Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Benign Prostatic Hyperplasia Stent Revenue Market Share by Region (2020-2031)
Figure 34. China Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Benign Prostatic Hyperplasia Stent Sales Market Share by Country (2020-2031)
Figure 42. Latin America Benign Prostatic Hyperplasia Stent Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Benign Prostatic Hyperplasia Stent Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Benign Prostatic Hyperplasia Stent Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Benign Prostatic Hyperplasia Stent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Benign Prostatic Hyperplasia Stent by Type (2020-2031)
Figure 53. Global Revenue Market Share of Benign Prostatic Hyperplasia Stent by Type (2020-2031)
Figure 54. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Benign Prostatic Hyperplasia Stent by Application (2020-2031)
Figure 56. Global Revenue Market Share of Benign Prostatic Hyperplasia Stent by Application (2020-2031)
Figure 57. Global Benign Prostatic Hyperplasia Stent Price (US$/Unit) by Application (2020-2031)
Figure 58. Benign Prostatic Hyperplasia Stent Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
